Unusual Case of Neuromeningeal Late Relapse of POLE Mutated Endometrioid Carcinoma: A Case Report and Systematic Review
Current Oncology · 16.04.2026 · 33 (4) · 219
DOI: 10.3390/curroncol33040219 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Current Oncology, online erschienen am 16.04.2026. Verfasst von Emma Donati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), 34090 Montpellier, France. Hauptthemen laut MEDLINE: Carcinoma, Endometrioid, Endometrial Neoplasms, Neoplasm Recurrence, Local, DNA Polymerase II. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
POLE-mutated endometrial carcinomas are associated with exceptionally favorable outcomes, forming the basis for treatment de-escalation in early-stage disease. Nevertheless, rare adverse clinical courses have been reported. This study describes an unusual case of late metastatic recurrence in a POLE-mutated tumor and provides a review of similar cases in the literature.
Methods
We present a detailed clinical, radiological, pathological, and molecular description of a patient who developed metastatic recurrence 16 years after initial surgery. A systematic literature search was conducted to identify reports of recurrence, progression, or cancer-related death in POLE-mutated endometrial carcinoma, with extraction of recurrence patterns, genomic features, treatment, and outcomes.
Results
The patient experienced sequential pulmonary, cerebral, and leptomeningeal metastases despite harboring a canonical POLE hotspot mutation, proficient mismatch repair status, wild-type TP53, no additional known driver mutation beyond PTEN alterations. The literature review identified a small number of similarly adverse cases. Reported recurrences were heterogeneous, though distant and occasionally central nervous system involvement were noted.
Conclusions
While POLE-mutated tumors overall retain an excellent prognosis, rare cases may follow an atypical and aggressive course. Improved molecular annotation and integrated risk-stratification models are needed to better identify this minority of higher-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), 34090 Montpellier, France.
- Groupe d'Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire et du Sein (GINECO), 75008 Paris, France.
- Department of Radiation Oncology, Institut du Cancer de Montpellier (ICM), 34090 Montpellier, France.
- Department of Pathology, Institut du Cancer de Montpellier (ICM), 34090 Montpellier, France.
- Department of Radiology, Institut du Cancer de Montpellier (ICM), 34090 Montpellier, France.
- Department of Surgical Oncology, Institut du Cancer de Montpellier (ICM), 34090 Montpellier, France.
ORCID-Profile: Emma Donati, Michel Fabbro, Alexis Marguerit, Pierre-Emmanuel Colombo, Stanislas Quesada
Zitieren
APA
Donati, E., Fabbro, M., Drappier, N., Marguerit, A., Leaha, C., Nougaret, S., Colombo, P. E., & Quesada, S. (2026). Unusual Case of Neuromeningeal Late Relapse of POLE Mutated Endometrioid Carcinoma: A Case Report and Systematic Review. Current Oncology, 33(4), 219. https://doi.org/10.3390/curroncol33040219
Vancouver
Donati E, Fabbro M, Drappier N, Marguerit A, Leaha C, Nougaret S, et al. Unusual Case of Neuromeningeal Late Relapse of POLE Mutated Endometrioid Carcinoma: A Case Report and Systematic Review. Current Oncology. 2026;33(4):219. doi:10.3390/curroncol33040219
BibTeX
@article{Donati2026,
author = {Donati, Emma and Fabbro, Michel and Drappier, Noémie and Marguerit, Alexis and Leaha, Cristina and Nougaret, Stéphanie and Colombo, Pierre-Emmanuel and Quesada, Stanislas},
title = {Unusual Case of Neuromeningeal Late Relapse of POLE Mutated Endometrioid Carcinoma: A Case Report and Systematic Review},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {4},
pages = {219},
doi = {10.3390/curroncol33040219}
}
EUVIMED